Cleared Special

K182988 - Afinion HbA1c Dx on Afinion 2

K182988 is the FDA 510(k) clearance for Afinion HbA1c Dx on Afinion 2 by Alere Technologies AS. It is a Class 2 Chemistry device (product code PDJ) cleared through the Special 510(k) pathway after a 31-day FDA review.

K182988 · Alere Technologies AS · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
31d
Days
Class 2
Risk

K182988 is an FDA 510(k) clearance for the Afinion HbA1c Dx on Afinion 2. Classified as Hemoglobin A1c Test System (product code PDJ), Class II - Special Controls.

Submitted by Alere Technologies AS (Oslo, NO). The FDA issued a Cleared decision on November 29, 2018 after a review of 31 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1373 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Alere Technologies AS devices

Submission Details

510(k) Number K182988 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 2018
Decision Date November 29, 2018
Days to Decision 31 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 88d · This submission: 31d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code PDJ Hemoglobin A1c Test System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1373
Definition Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - PDJ Hemoglobin A1c Test System

All 20
Devices cleared under the same product code (PDJ) and FDA review panel - the closest regulatory comparables to K182988.
ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) Assay
K200256 · Siemens Healthcare Diagnostics, Inc. · Jul 2021
Tina-quant Hemoglobin A1cDx Gen.3
K193053 · Roche Diagnostics Operations (Rdo) · Mar 2020
HbA1c Advanced
K182651 · Beckman Coulter Ireland, Inc. · Jan 2019
Dimension Hemoglobin A1c Assay
K173909 · Siemens Healthcare Diagnostics, Inc. · Jul 2018
SEKURE HbA1c Assay
K173206 · Sekisui Diagnostics P.E.I., Inc. · Jul 2018
Afinion HbA1c Dx
K180296 · Alere Technologies AS · May 2018